Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

And with Nasrat owning the preferred shares, he

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lostatsea Member Profile
 
Followed By 11
Posts 679
Boards Moderated 0
Alias Born 11/05/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 5:04:10 PM
Elite Pharmaceuticals reports FQ3 results Seeking Alpha - 2/16/2021 4:41:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/16/2021 4:23:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 4:41:44 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 4:05:06 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/1/2020 4:04:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 5:25:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 2:19:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 2:15:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/24/2020 2:11:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/17/2020 6:22:01 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2020 4:04:56 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/31/2020 5:01:17 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/28/2020 6:05:03 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 7/27/2020 5:25:39 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/15/2020 5:03:23 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 7/13/2020 12:50:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/9/2020 5:03:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/6/2020 11:39:07 AM
The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI) InvestorsHub NewsWire - 7/6/2020 9:16:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2020 6:41:08 AM
Annual Report (10-k) Edgar (US Regulatory) - 6/30/2020 6:38:17 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/11/2020 4:51:17 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2020 5:22:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2020 6:07:02 AM
lostatsea   Thursday, 08/06/20 01:42:03 PM
Re: IB_ post# 340655
Post # of 352687 
And with Nasrat owning the preferred shares, he has cleverly and dramatically increased his equity ownership in the company. While the company continues to dilute - which, will dilute Nasrat's common shares and other ordinary shareholders - in reality, ownership is being transferred from those common shares to the preferred at a much greater rate of value. Nasrat loses a percentage of his common shares value via dilution (as we all do), but his preferred grows at a much greater rate than his dilution; e.g. (this is just an example of how it works, I haven't calculated the actual numbers) he will lose 1% of ownership of his common to dilution, but gain 3% total ownership in a preferred conversion - this of course at the expense of ordinary common shareholders.

At least that's the way I understand the filings.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences